AAAAAA

   
Results: 1-22 |
Results: 22
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model
Authors: Chakraborty, H Sen, PK Helms, RW Vernazza, PL Fiscus, SA Eron, JJ Patterson, BK Coombs, RW Krieger, JN Cohen, MS
Citation: H. Chakraborty et al., Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model, AIDS, 15(5), 2001, pp. 621-627
A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding
Authors: Al-Harthi, L Kovacs, A Coombs, RW Reichelderfer, PS Wright, DJ Cohen, MH Cohn, J Cu-Uvin, S Watts, H Lewis, S Beckner, S Landay, A
Citation: L. Al-harthi et al., A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding, AIDS, 15(12), 2001, pp. 1535-1543
Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: Implications for applying measurements to individual women
Authors: Coombs, RW Wright, DJ Reichelderfer, PS Burns, DN Cohn, J Cu-Uvin, S Baron, PA Cohen, MH Landay, AL Lewis, S Kovacs, A
Citation: Rw. Coombs et al., Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: Implications for applying measurements to individual women, J INFEC DIS, 184(9), 2001, pp. 1187-1191
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine - AIDS clinical trials group protocol 320
Authors: Demeter, LM Hughes, MD Coombs, RW Jackson, JB Grimes, JM Bosch, RJ Fiscus, SA Spector, SA Squires, KE Fischl, MA Hammer, SM
Citation: Lm. Demeter et al., Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine - AIDS clinical trials group protocol 320, ANN INT MED, 135(11), 2001, pp. 954-964
Association of antiretroviral therapy with detection of HIV-1 RNA and DNA in the anorectal mucosa of homosexual men
Authors: Lampinen, TM Critchlow, CW Kuypers, JM Hurt, CS Nelson, PJ Hawes, SE Coombs, RW Holmes, KK Kiviat, NB
Citation: Tm. Lampinen et al., Association of antiretroviral therapy with detection of HIV-1 RNA and DNA in the anorectal mucosa of homosexual men, AIDS, 14(5), 2000, pp. F69-F75
Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract
Authors: Reichelderfer, PS Coombs, RW Wright, DJ Cohn, J Burns, DN Cu-Uvin, S Baron, PA Cohen, MH Landay, AL Beckner, SK Lewis, SR Kovacs, AA
Citation: Ps. Reichelderfer et al., Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract, AIDS, 14(14), 2000, pp. 2101-2107
Comparison of assays to detect cytomegalovirus shedding in the semen of HIV-infected men
Authors: Diamond, C Speck, C Huang, ML Corey, L Coombs, RW Krieger, JN
Citation: C. Diamond et al., Comparison of assays to detect cytomegalovirus shedding in the semen of HIV-infected men, J VIROL MET, 90(2), 2000, pp. 185-191
Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma
Authors: Erice, A Brambilla, D Bremer, J Jackson, JB Kokka, R Yen-Lieberman, B Coombs, RW
Citation: A. Erice et al., Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma, J CLIN MICR, 38(8), 2000, pp. 2837-2845
Multicenter evaluation of methods to quantitate human immunodeficiency virus type 1 RNA in seminal plasma
Authors: Fiscus, SA Brambilla, D Coombs, RW Yen-Lieberman, B Bremer, J Kovacs, A Rasheed, S Vahey, M Schutzbank, T Reichelderfer, PS
Citation: Sa. Fiscus et al., Multicenter evaluation of methods to quantitate human immunodeficiency virus type 1 RNA in seminal plasma, J CLIN MICR, 38(6), 2000, pp. 2348-2353
Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS Clinical Trials Group protocol 333
Authors: Para, MF Glidden, DV Coombs, RW Collier, AC Condra, JH Craig, C Bassett, R Leavitt, R Snyder, S McAuliffe, V Boucher, C
Citation: Mf. Para et al., Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS Clinical Trials Group protocol 333, J INFEC DIS, 182(3), 2000, pp. 733-743
Reduced mobilization of CD34(+) stem cells in advanced human immunodeficiency virus type 1 disease
Authors: Schooley, RT Mladenovic, J Sevin, A Chiu, S Miles, SA Pomerantz, RJ Campbell, TB Bell, D Ambruso, D Wong, R Landay, A Coombs, RW Fox, L Kamoun, M Jacovini, J
Citation: Rt. Schooley et al., Reduced mobilization of CD34(+) stem cells in advanced human immunodeficiency virus type 1 disease, J INFEC DIS, 181(1), 2000, pp. 148-157
Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells
Authors: Campbell, TB Sevin, A Coombs, RW Peterson, GC Rosandich, M Kuritzkes, DR Mladenovic, J Landay, A Wong, R Ambruso, D Miles, S Pomerantz, RJ Schooley, RT
Citation: Tb. Campbell et al., Changes in human immunodeficiency virus type 1 virus load during mobilization and harvesting of hemopoietic progenitor cells, BLOOD, 95(1), 2000, pp. 48-55
HIV-1 dynamics in children
Authors: Melvin, AJ Rodrigo, AG Mohan, KM Lewis, PA Manns-Arcuino, L Coombs, RW Mullins, JI Frenkel, LM
Citation: Aj. Melvin et al., HIV-1 dynamics in children, J ACQ IMM D, 20(5), 1999, pp. 468-473
The HIV type 1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance
Authors: Vaillancourt, M Irlbeck, D Smith, T Coombs, RW Swanstrom, R
Citation: M. Vaillancourt et al., The HIV type 1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance, AIDS RES H, 15(4), 1999, pp. 355-363
The HIV-1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance (vol 15, pg 355, 1999)
Authors: Vaillancourt, M Irlbeck, D Smith, T Coombs, RW Swanstrom, R
Citation: M. Vaillancourt et al., The HIV-1 protease inhibitor saquinavir can select for multiple mutations that confer increasing resistance (vol 15, pg 355, 1999), AIDS RES H, 15(10), 1999, pp. 949-949
The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements
Authors: Brambilla, D Reichelderfer, PS Bremer, JW Shapiro, DE Hershow, RC Katzenstein, DA Hammer, SM Jackson, B Collier, AC Sperling, RS Fowler, MG Coombs, RW
Citation: D. Brambilla et al., The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements, AIDS, 13(16), 1999, pp. 2269-2279
Determination of indinavir, a HIV-1 protease inhibitor, in human plasma using ion-pair reversed-phase high-performance liquid chromatography
Authors: Li, WZ Coombs, RW Collier, AC Raisys, VA
Citation: Wz. Li et al., Determination of indinavir, a HIV-1 protease inhibitor, in human plasma using ion-pair reversed-phase high-performance liquid chromatography, THER DRUG M, 21(3), 1999, pp. 360-366
Unintegrated HIV-1 circular 2-LTR proviral DNA as a marker of recently infected cells: Relative effect of recombinant CD4, zidovudine, and saquinavirin vitro
Authors: Panther, LA Coombs, RW Aung, SA dela Rosa, C Gretch, D Corey, L
Citation: La. Panther et al., Unintegrated HIV-1 circular 2-LTR proviral DNA as a marker of recently infected cells: Relative effect of recombinant CD4, zidovudine, and saquinavirin vitro, J MED VIROL, 58(2), 1999, pp. 165-173
Effect of zidovudine on perinatal HIV-1 transmission and maternal viral load
Authors: Shapiro, DE Coombs, RW Sperling, RS
Citation: De. Shapiro et al., Effect of zidovudine on perinatal HIV-1 transmission and maternal viral load, LANCET, 354(9173), 1999, pp. 156-156
The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076)
Authors: McSherry, GD Shapiro, DE Coombs, RW McGrath, N Frenkel, LM Britto, P Culnane, M Sperling, RS
Citation: Gd. Mcsherry et al., The effects of zidovudine in the subset of infants infected with human immunodeficiency virus type-1 (Pediatric AIDS Clinical Trials Group Protocol 076), J PEDIAT, 134(6), 1999, pp. 717-724
Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS Clinical Trials Group 229
Authors: Schapiro, JM Lawrence, J Speck, R Winters, MA Efron, B Coombs, RW Collier, AC Merigan, TC
Citation: Jm. Schapiro et al., Resistance mutations to zidovudine and saquinavir in patients receiving zidovudine plus saquinavir or zidovudine and zalcitabine plus saquinavir in AIDS Clinical Trials Group 229, J INFEC DIS, 179(1), 1999, pp. 249-253
Risk factors for HIV-1 shedding in semen
Authors: Speck, CE Coombs, RW Koutsky, LA Zeh, J Ross, SO Hooton, TM Collier, AC Corey, L Cent, A Dragavon, J Lee, W Johnson, EJ Sampoleo, RR Krieger, JN
Citation: Ce. Speck et al., Risk factors for HIV-1 shedding in semen, AM J EPIDEM, 150(6), 1999, pp. 622-631
Risultati: 1-22 |